WO1985004346A1 - Process for preparing w/o/w complex emulsion for medicinal and cosmetic use - Google Patents
Process for preparing w/o/w complex emulsion for medicinal and cosmetic use Download PDFInfo
- Publication number
- WO1985004346A1 WO1985004346A1 PCT/JP1985/000143 JP8500143W WO8504346A1 WO 1985004346 A1 WO1985004346 A1 WO 1985004346A1 JP 8500143 W JP8500143 W JP 8500143W WO 8504346 A1 WO8504346 A1 WO 8504346A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- emulsion
- type
- water
- phase
- added
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 171
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 39
- 239000002537 cosmetic Substances 0.000 title abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 70
- 239000002131 composite material Substances 0.000 claims description 68
- 239000003995 emulsifying agent Substances 0.000 claims description 54
- 239000012071 phase Substances 0.000 claims description 51
- -1 linoleic acid ester Chemical class 0.000 claims description 44
- 229960003656 ricinoleic acid Drugs 0.000 claims description 39
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 claims description 39
- 239000008346 aqueous phase Substances 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- 235000002639 sodium chloride Nutrition 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 229910052708 sodium Inorganic materials 0.000 claims description 10
- 102000002322 Egg Proteins Human genes 0.000 claims description 6
- 239000005018 casein Substances 0.000 claims description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 6
- 235000021240 caseins Nutrition 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 108010000912 Egg Proteins Proteins 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- 229920001817 Agar Polymers 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000008272 agar Substances 0.000 claims description 4
- 239000000783 alginic acid Substances 0.000 claims description 4
- 229960001126 alginic acid Drugs 0.000 claims description 4
- 150000004781 alginic acids Chemical class 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 4
- 229920000858 Cyclodextrin Polymers 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 210000002969 egg yolk Anatomy 0.000 claims description 3
- 235000013345 egg yolk Nutrition 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 108010073771 Soybean Proteins Proteins 0.000 claims description 2
- 240000004584 Tamarindus indica Species 0.000 claims description 2
- 235000004298 Tamarindus indica Nutrition 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 229920000591 gum Polymers 0.000 claims description 2
- 235000019710 soybean protein Nutrition 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 241000416162 Astragalus gummifer Species 0.000 claims 1
- 239000001879 Curdlan Substances 0.000 claims 1
- 229920002558 Curdlan Polymers 0.000 claims 1
- 229920002907 Guar gum Polymers 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 229920001615 Tragacanth Polymers 0.000 claims 1
- 239000005862 Whey Substances 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 238000004040 coloring Methods 0.000 claims 1
- 235000019316 curdlan Nutrition 0.000 claims 1
- 229940078035 curdlan Drugs 0.000 claims 1
- 229960002086 dextran Drugs 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 239000000665 guar gum Substances 0.000 claims 1
- 235000010417 guar gum Nutrition 0.000 claims 1
- 229960002154 guar gum Drugs 0.000 claims 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 1
- 235000020778 linoleic acid Nutrition 0.000 claims 1
- 229920000609 methyl cellulose Polymers 0.000 claims 1
- 239000001923 methylcellulose Substances 0.000 claims 1
- 235000010981 methylcellulose Nutrition 0.000 claims 1
- 235000010487 tragacanth Nutrition 0.000 claims 1
- 239000000196 tragacanth Substances 0.000 claims 1
- 229940116362 tragacanth Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 28
- 150000002148 esters Chemical class 0.000 abstract description 27
- 229940079593 drug Drugs 0.000 abstract description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 58
- 239000003921 oil Substances 0.000 description 38
- 235000019198 oils Nutrition 0.000 description 37
- 239000006071 cream Substances 0.000 description 32
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 30
- 235000011187 glycerol Nutrition 0.000 description 29
- 239000000203 mixture Substances 0.000 description 26
- 239000007864 aqueous solution Substances 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 19
- 238000009833 condensation Methods 0.000 description 17
- 230000005494 condensation Effects 0.000 description 17
- 102000004877 Insulin Human genes 0.000 description 15
- 108090001061 Insulin Proteins 0.000 description 15
- 229940125396 insulin Drugs 0.000 description 15
- 238000004945 emulsification Methods 0.000 description 14
- 239000006210 lotion Substances 0.000 description 14
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 229940099259 vaseline Drugs 0.000 description 10
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 8
- 235000013871 bee wax Nutrition 0.000 description 8
- 239000012166 beeswax Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 230000001804 emulsifying effect Effects 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000004166 Lanolin Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 235000019388 lanolin Nutrition 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- 239000001587 sorbitan monostearate Substances 0.000 description 6
- 235000011076 sorbitan monostearate Nutrition 0.000 description 6
- 229940035048 sorbitan monostearate Drugs 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 239000008269 hand cream Substances 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- ZEMPKEQAKRGZGQ-VBJOUPRGSA-N triricinolein Chemical group CCCCCC[C@@H](O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC)COC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-VBJOUPRGSA-N 0.000 description 5
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 4
- 239000005977 Ethylene Substances 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 235000013355 food flavoring agent Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000008173 hydrogenated soybean oil Substances 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000001593 sorbitan monooleate Substances 0.000 description 4
- 235000011069 sorbitan monooleate Nutrition 0.000 description 4
- 229940035049 sorbitan monooleate Drugs 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- KGWDUNBJIMUFAP-KVVVOXFISA-N Ethanolamine Oleate Chemical compound NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O KGWDUNBJIMUFAP-KVVVOXFISA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241001474791 Proboscis Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229940092738 beeswax Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 235000021239 milk protein Nutrition 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 101710186643 Insulin-2 Proteins 0.000 description 1
- 241000134253 Lanka Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000353097 Molva molva Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241001495428 Prostoma Species 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 241000288961 Saguinus imperator Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- 235000001468 Triticum dicoccon Nutrition 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000011950 custard Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- ABOOHAAPKSGHOJ-UHFFFAOYSA-N ethenoxyborane Chemical group BOC=C ABOOHAAPKSGHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- RCRODHONKLSMIF-UHFFFAOYSA-N isosuberenol Natural products O1C(=O)C=CC2=C1C=C(OC)C(CC(O)C(C)=C)=C2 RCRODHONKLSMIF-UHFFFAOYSA-N 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- 210000001944 turbinate Anatomy 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000003357 wound healing promoting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/066—Multiple emulsions, e.g. water-in-oil-in-water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/4105—Methods of emulsifying
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/34—Higher-molecular-weight carboxylic acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/414—Emulsifying characterised by the internal structure of the emulsion
- B01F23/4144—Multiple emulsions, in particular double emulsions, e.g. water in oil in water; Three-phase emulsions
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S516/00—Colloid systems and wetting agents; subcombinations thereof; processes of
- Y10S516/924—Significant dispersive or manipulative operation or step in making or stabilizing colloid system
- Y10S516/925—Phase inversion
Definitions
- the present invention provides an extremely fine and highly stable W
- This paper relates to a method for producing Z o Zw type complex emulsions.
- the present invention relates to a method for producing a wzo-zw type composite emulsion having excellent heat stability for use in pharmaceuticals and cosmetics other than foods.
- An object of the present invention is to produce a wzozw type composite emulsion that is used for producing various emulsified dispersion products such as pharmaceuticals and cosmetics.
- wzo/w-type composite emulsions are fine-grained and extremely smooth in contact with the skin, etc., and are capable of encapsulating water-soluble substances in the circles of the fat globules. Because of this, it is expected to be used in many applications such as cosmetics, pharmaceuticals, and foodstuffs, because it can increase the apparent gift rate.
- lyserin-condensed ricinoleic acid ester (olylyeero) is used as an emulsifier. 1
- DO lyric i no la te (same as po Iyg-lycero I esters of polycondensed fatty acids of castor oil)
- excellent complex emulsions were formed. I succeeded in getting it.
- the amount of emulsifier can be reduced, and the W/O type composite obtained can be obtained.
- Emulsions are very stable to heat, resistant to caking, and stable to long-term storage.
- the internal water phase is extremely small, has a high production rate, and is stable even after physical treatment after production. Description of drawings that may be included
- FIG. 1 is a graph showing the production rate of wZ0Zw type complex emulsions in Example 5, with different emulsifiers having varying degrees of emulsifier.
- one kind or a mixture of two or more kinds appropriately selected from the boliglycerin-condensed ricinolein esters represented by the general formula herein is used.
- the addition of the bolidalyserine condensed ricinoleic acid ester can Either one is fine, and it is difficult to dissolve it.
- the amount added is 0.120%, preferably 115%, more preferably 110%, relative to the amount of oil used.
- Other emulsifiers may also be added as required. As other emulsifiers, any emulsifiers may be used, but lecithin and/or di-fatty long esters of glycerin are preferable.
- the oily substance may be beeswax, lanolin, vaseline, raffin, vegetable oil, vegetable oil, etc., but hydrogenated oil is used. In some cases, it is heated and melted for convenient use. Separately prepare water, which contains protein, starches, gums, emulsifiers, phosphorus and its salts, oleic acid and its salts, coloring agents, flavoring agents, etc. Various additives, additives, chemicals, etc. may be mixed and left as an aqueous phase, or may be heated.
- One method for complex emulsification of the WZOZW type in the present invention is to sequentially add and mix the water phase to which the present emulsifier has been added to the oil starch to which the present emulsifier has been added, and obtain a wZ0 type emulsion. It is a method of mixing and emulsifying into wozw type complex emulsification at once.
- another method in the present invention there is a method of first producing a W/0 type emulsion, and there are two methods for this. The first is a method in which an aqueous phase is successively added to an oil phase to which the present emulsifier has been added, directly forming a WZO type emulsion.
- a W/0 type emulsion having fine water erosion can be obtained by any of the above-mentioned methods. uniform water? It's better because it gives you an if.
- the amounts of the oily substance and water may be appropriate according to the purpose, but for the next phase inversion, the oily substance:water ratio is about 3: to 1:3.
- the resulting OZW type emulsion is phase-inverted to the wzo type by sufficiently stirring it with a homomixer.
- This ternary phase makes it possible to obtain a very fine and highly crystalline ternary emulsion.
- various additives such as drugs can be sealed in the water phase in the oil. At this time, it is stirred with a homomixer, for example
- this wzo-type emulsion should be heated at 50 to 80°C to improve the subsequent emulsification. It is prepared as follows. Water, casein, sodium casein, gelatin, citrus, wheat tongue. ku, starch, processing? Starch, soybean tongue. protein, plasma protein, milk protein, egg white, egg yolk, dextrin, cyclodextrin, starch derivative, custard gum, xanthan gum, f.
- Luran dexterin, ryokudoran, gua - ryoku, mu, tamarind gum, agar, carrageenan, farseran, agar Luggic acid and its salts, alginic acid prohi. Leng glycol estenole, pectin, alabinoga' lactan lactan senololose, CMC, methylol cerolose, arabic Gum, Tolaganth gum, Caraja gum, Sodium boriaacrylate, Others Ortholine: acid, ⁇ . Lorin ⁇ , Borilin Rice husks, salts thereof, table salt, vinegar, organic iron or salts thereof, emulsifiers or mixtures thereof, etc. are added.
- emulsifiers used herein include sucrose fatty acid ester, lyoxyethylene sorbitan fatty ester, f. Norhenic active agents, telonic active agents, etc. are available. In addition, coloring agents, flavoring agents, etc. are added depending on JS. This water phase is 5 [! It should be heated to about 8 Q. The order of addition may be any, but for convenience of operation, the WZO type emulsion is first put into the agitator, and then the water phase to which the emulsifier and the like are added is put.
- the crushers used here include those with stirring blades near the bottom, suction type with stirring blades over the entire surface, suction type crushers with only 1 go, Mixer, homogenizer, and votator may be mixed with a high degree of mixing, but the impact on the W-0 type emulsion at the top is weak and stable.
- a 0_/ W-type composite emulsion is prepared. c Mix this aqueous phase with the above wz 0-type emulsion, and stir with a stirrer, for example, at 25 Q rpm for 5 minutes. Mix well and then homogenize. What is obtained here is a type complex emulsion, which is an extremely fine emulsion.
- a WZOZW type composite emulsion that has extremely fine water droplets and is stable.
- Cosmetics include emolien cream, cleansing cream, base cream, massage cream, nourishing cream. Creams such as creams, hand creams and hair creams, or moisturizer lotions, cleansing lotions, Aftershave, lotion, tongue mouth, hair treatment, hair treatment Lotions, etc., and other cosmetics are manufactured.
- Oral medicines, injections, suppositories, etc. are manufactured as internal medicines.
- Test example 2 type of external aqueous phase emulsifier
- Example 2 In the same treatment as in Example 1, the type of glycerin and lycinolein ester and the type of emulsifier in the external aqueous phase were changed, and 1 part of lycerin condensed lysinolein ester was added to the oil, and 2 parts of the emulsifier for the external water phase was added to the external water. were produced, and the formation rate of each WZOZW-type composite emulsion was examined. The results are shown in Table-5. The formation rate of the W/0W type composite emulsion was measured by the method of Experimental Example 1.
- a boliglyceryl-condensed ricinoleic acid ester is remarkably effective in obtaining a WZOZW type complex emulsion. I can feel it tickling.
- W/0 type composite emulsions were produced in the same manner as in Example 5, except for the following changes, and the average sclera diameter and wzo/w type composite em- mer were measured. The generation rate of noresion was observed.
- lidar lyserine condensed lysinolein ester was added at a concentration of 1.0 to oil, and the rest was carried out in the same manner as in Test Example 5.
- Boliglycerin condensed lysinolein ester was used at a ratio of 1.0 to the oil, but the water phase was added to the oil phase to prepare the primary emulsion. After that, the same method as in Test Example 5 was used.
- W/0/w-type composite emulsions were produced with an additive force U of 1/100 against the oil, and the average water diameter and W/0/W-type composite emulsion were measured.
- the rate of formation of emulsions and WZOZW-type composite emulsions after storage at 5 for 1 month and after heating at 12 Q for 3 min were examined. The result is shown in the following table - ⁇ -1 ⁇ one
- the formation rate of the W-type composite emulsion was measured by the method of Example 5.
- the resulting cleansing cream did not have a greasy feeling and gave a very light laxative feeling.
- the creaminess was very good, the cleansing effect was excellent, and the emulsification was stable.
- 100 parts by weight of the above WZ0 type emulsion was divided into 4 parts of 10 lyoxyethylene sorbitan monolithic aqueous solution of 2 ⁇ weight.
- the emulsion was re-emulsified with a homomixer at 0 to obtain a massage cream having a basic form of a 0Z Wou composite emulsion.
- W/0 type emulsion 100 parts by weight of W/0 type emulsion is added to 2 Q parts by weight of an aqueous solution of 1 Q polyoxyethylene sorbitan monouraureate. Disperse and re-emulsify with a homomixer at 8 Q to make a WZ 0 ZW type complex emulsion as a basic form. I got a reel.
- Insulin 2 Q 0 Q units were dissolved in 0.1N hydrochloric acid 8/ ⁇ to obtain an insulin-containing aqueous solution.
- soybean oil 2QQu and boriglycerin condensed ricinoleic acid ester 1 ⁇ ? is dissolved, and the insulin-containing aqueous solution is added thereto and emulsified for 1 Q minutes with a high-pressure emulsifier to obtain a WZO type emulsion.
- the above WZO emulsion was diluted with 5 and re-emulsified with a homomixer to obtain a wound healing agent having a W/OZW type composite emulsion as a basic form. .
- a process for preparing a W/O/W complex emulsion using polyglycerin-condensed ricinoleic ester This process enables to remarkably raise the yield of W/O/W complex emulsion. heat stability, thus being extremely useful in the field of medicines and cosmetics.
- the present invention is a method of using a boliglycerin-condensed ricinoleic acid ester in the production of a wzo/w type composite emulsion.
- lidalyserine condensed ricinoleic acid ester By using lidalyserine condensed ricinoleic acid ester, the formation rate of the w/ozw type composite emulsion is remarkably increased.
- the resulting wzozw-type complex emulsion is stable for a long period of time. It also has excellent heat stability and is extremely useful in the fields of pharmaceuticals and cosmetics.
- the present invention relates to a method for producing a wZOZW type composite emulsion that is extremely fine and has excellent stability.
- the present invention relates to a method for producing a w0W type composite emulsion having excellent heat stability for pharmaceuticals, cosmetics, etc. other than foods.
- the object of the present invention is to produce a wzozw type composite emulsion that is used for producing various emulsified dispersion products such as pharmaceuticals and cosmetics.
- wzozw-type composite emulsions are characterized by their fine texture and extremely smooth contact with the skin, and the ability to enclose water-soluble substances inside the fat globules. And since it can increase the apparent flavor rate, it is expected to be used in many applications such as cosmetics, pharmaceuticals, and food and beverages.
- the emulsifier in the production of the wzozw type composite emulsion, is Glycerin condensed lycinoleic acid ester (olyglyeerol DO lyri e i no la te (same as polyglycerol esters of polycondensed fatty acids of castor oil)) is used.
- Glycerin condensed lycinoleic acid ester olyglyeerol DO lyri e i no la te (same as polyglycerol esters of polycondensed fatty acids of castor oil)
- a wzo-type composite emulsion can be obtained with a small amount of emulsifier by using a boliglycerin-condensed ricinoleic acid ester. It is very stable to heat, resistant to condensation, and stable to long-term storage. Since the internal water phase is extremely minute, the production rate is high, and it is stable even after physical treatment after production, it is possible to incorporate a large amount of various active ingredients into the internal water phase. Description of possible drawings
- Fig. 1 shows W Z
- FIG. 10 is a diagram showing the rate of formation of a 0 Zw type composite mulsion.
- Polyglycerin condensed ricinoleic acid used in the present invention One 5 —
- Ester is represented by the following formula (I).
- one or a mixture of two or more selected appropriately from lyglycerin-condensed ricinoleic acid esters represented by the general formula herein is used.
- Addition of the boliglycerin condensed ricinoleic acid ester is 3 ⁇ 4 Any one is fine, it does not need to be dissolved, and if it is not dissolved, it may be emulsified in a suspended state.
- the amount to be added is 0.1 to 2 Q, preferably 1 to 15%, more preferably 1 to 10%, relative to the amount of oil used. Further, other emulsifiers are appropriately added as necessary.
- Other emulsifiers may be any emulsifiers, such as lecithin and difatty acid esters of no or dalycerin.
- the oily substance may be beeswax, lanolin, vaseline, halo -raffin, animal oil, vegetable oil, etc., but hydrogenated oil is used. In some cases, it is heated and melted before use. Water is prepared separately, but water contains tanks, starches, gums, emulsifiers, phosphoric acid and its salts, organic acids and their salts, coloring agents, flavoring agents, etc. Various additives, additives, chemicals, etc. may be mixed and left as a permanent phase, or may be heated.
- One method of complex emulsification of the W/0W type in the present invention is to sequentially add and mix an aqueous phase to which the present emulsifier has been added to an oil phase to which the present emulsifier has been added, and obtain a w/o type emulsion.
- the emulsion is phase-inverted, and at that time, complex emulsification of the wzozw type occurs at once.
- Another method in the present invention is to first produce a W/0 type emulsion, and there are two methods.
- the first method is to sequentially add and mix the water phase with the oil phase to which the present emulsifier has been added to directly form a WZ0 type emulsion.
- the phases are sequentially added and mixed to form an OZW type emulsion, which is then stirred well to cause a secondary phase to form a WZ0 type emulsion.
- a wz 0 -type emulsion having fine water droplets can be obtained by any of the above methods, but the second method, which employs phase inversion, produces fine and uniform droplets. It is more preferable because it gives 3 ⁇ 4 phlegm.
- the amounts of the oily substance and water may be appropriate depending on the purpose, but for the next phase inversion, the oily substance:water ratio is about 5:1 to 1:3.
- the resulting OZW type emulsion is phase-inverted to the w/o type by sufficiently stirring it with a homomixer. This phase inversion makes it possible to obtain an extremely fine and smooth emulsion.
- various additives such as drugs can be sealed in the water phase in the oil. At this time, it is stirred with a homomixer, for example
- this WZ0 type emulsion should be heated to 5 (3 to 80 degrees Celsius ) in order to improve the subsequent milking .
- the phases are prepared as follows: in water, casein, sodium casein, gelatin, wheat starch, starch, processed?
- Starch soybean protein, plasma protein, milk protein, egg white, egg yolk, dextrin, cyclodextrin, starch derivative, Locus turbinate, mu, xanthan gum, pullulan, dextran, guar, rum, tamarin Degas, mu, agar, carrageenan, farcelleran, alginic acid and its salts, alginic acid fluoropyrene glycolestenol , pectin, alabinoga'lactan,
- An acid or a salt thereof, salt, vinegar, an organic acid or a salt thereof, an emulsifier, a mixture thereof, or the like is added.
- emulsifiers used herein include sucrose fatty acid esters, polyoxyethylene sorbitan and fatty acid esters, and pluronic actives. activator, tetronic activator, etc.
- coloring agents, flavoring agents, etc. are added depending on the purpose. This aqueous phase is kept at 5° C. for good emulsification. Power of moderately warmed at ⁇ 8 Q; good.
- the order of addition may be any, but for convenience of operation, the WZO type emulsion is first put into the stirrer, and then the water phase to which the emulsifier and the like are added is put.
- the mixer is equipped with a Tf stirring blade near the bottom, a suction type with stirring blades over the entire surface, a mixer that only suctions and mixes, a homomixer, Homogenizer, bottler, or any type of stirrer is acceptable, but the impact on the W0 type emulsion at the top is weak and stable. Those from which mullions are prepared are preferred.
- This aqueous phase and the above wzo-type emulsion are mixed, stirred and mixed with a stirrer at, for example, 25 Q rpm for 5 minutes, and then treated with a homogenizer.
- a type complex emulsion which is an extremely fine emulsion.
- cosmetics include emolien cream, cleansing cream, base cream, massage cream, nourishing cream. , hand cream, hair cream and other creams, or moisturizer lotion, cleansing lotion, hair cream, etc. Shave lotion, suntan lotion, nose lotion, hair treatment, etc. ⁇ -Shayons and other cosmetics are manufactured.
- Oral medicines, injections, and suppositories are manufactured as internal medicines.
- the formation rate of the wzo/w type composite emulsion was measured according to the method of Matsumoto et al. . Clothing ⁇
- Test Example 2 (Type of external aqueous phase emulsifier)
- Test IJ 1 mono- or Tests were conducted with glycerin polymerized for 11% oil and with different degrees of esterification of ricinoleic acid. The results are shown in Table-4. Table-4
- the numbers represent the production rate %. It is a mixture of esters having a polymerization degree of phosphorus of 5-4 and a condensation degree of ricinolein of 4-5.
- the formation rate of the W/0ZW type composite emulsion was determined by the method of Matsumoto et al. followed.
- a W0ZW type composite emulsion was produced in the same manner as in Test Example 5, except for the following changes. We looked at the generation rate of the leukion.
- Boliglycerin-condensed ricinoleic acid ester was used in an amount of 1.Q% to oil, and the rest was carried out in the same manner as in Test Example 5.
- Boliglycerin condensed ricinoleic acid ester was used at 1.0% relative to the oil, but the water phase was added to the oil phase to perform primary emulsification. After that, the same method as in Test Example 5 was used.
- the obtained cleansing cream was not oily and had a very light feeling during use.
- the spread of the cream was extremely good, the cleansing effect was not good, and the emulsified state was stable.
- Vaseline 50 I' 3. Cured fat .1 weight
- the above WZ0 type emulsion 1Q0 parts by weight was divided into 20 parts by weight of a 10 boroxyethylene sorbitan monooleate aqueous solution, and Then, the mixture was re-emulsified with a homomixer to obtain a massage cream having a W 0 / W type composite emulsion as a basic form.
- Vaseline 1 0. 0
- An insulin-containing aqueous solution was prepared by dissolving 12,000 units of insulin in 8 parts of 0.1N hydrochloric acid.
- salad oil 3Q mi boliglycerin condensed ricinoleic acid ester 5 ⁇ was dissolved, and a small amount of the above insulin-containing aqueous solution was dripped into it.
- a w/0 type emulsion was obtained by emulsifying the mixture for ⁇ minutes using an ultrasonic generator.
- the insulin-containing w/o_w type composite emulsion preparation was prepared by emulsifying for 5 minutes with
- a polyglycerin-condensed ricinoleic acid ester 1Q ⁇ was dissolved in soybean oil 2Q0, and the above-mentioned insulin-containing aqueous solution was added to the solution. Then, emulsify with a high-pressure emulsifier for 10 minutes to obtain a wzo type emulsion.
- the above-mentioned W0 type emulsion is dispersed in 5 and re-emulsified with a homomixer to form a WZO/W type composite emulsion as a basic form of a healing agent. got
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Medicinal Preparation (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08524315A GB2165163B (en) | 1984-03-26 | 1985-03-25 | Process for preparing w/o/w complex emulsion for medicinal and cosmetic use |
NL8520061A NL8520061A (nl) | 1984-03-26 | 1985-03-25 | Werkwijze voor de bereiding van een emulsie van het w/o/w-type. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59056324A JPS60199833A (ja) | 1984-03-26 | 1984-03-26 | 医薬品、化粧品等用w/o/w型複合エマルジヨンの製造法 |
JP59/056324 | 1984-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1985004346A1 true WO1985004346A1 (en) | 1985-10-10 |
Family
ID=13023993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1985/000143 WO1985004346A1 (en) | 1984-03-26 | 1985-03-25 | Process for preparing w/o/w complex emulsion for medicinal and cosmetic use |
Country Status (7)
Country | Link |
---|---|
US (4) | US4931210A (ja) |
EP (1) | EP0174377B2 (ja) |
JP (1) | JPS60199833A (ja) |
DE (1) | DE3590135T1 (ja) |
GB (1) | GB2165163B (ja) |
NL (1) | NL8520061A (ja) |
WO (1) | WO1985004346A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4409569C1 (de) * | 1994-03-21 | 1995-08-10 | Henkel Kgaa | Polyglycerinpolyricinoleate |
US5840943A (en) * | 1994-06-13 | 1998-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Polyolpolyhydroxystearates |
US6264961B1 (en) | 1995-09-11 | 2001-07-24 | Henkel Kommanditgesellschaft Auf Aktien | Oil-water emulsifiers |
WO2014045410A1 (ja) * | 2012-09-21 | 2014-03-27 | キユーピー株式会社 | 乳化調味料 |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60199833A (ja) * | 1984-03-26 | 1985-10-09 | Meiji Milk Prod Co Ltd | 医薬品、化粧品等用w/o/w型複合エマルジヨンの製造法 |
US4874605A (en) * | 1987-11-27 | 1989-10-17 | Hoechst-Roussel Pharmaceuticals Inc. | Stabilized delayed release emulsion |
US5264460A (en) * | 1988-05-30 | 1993-11-23 | Deutsche Solvay-Werke Gmbh | Process for preparing nonionic surfactants |
US5258184A (en) * | 1988-06-03 | 1993-11-02 | Unilever Patent Holdings B.V. | Emulsions |
US5171737A (en) * | 1989-03-03 | 1992-12-15 | The Liposome Company, Inc. | Emulsions |
FR2649012B1 (fr) * | 1989-07-03 | 1991-10-25 | Seppic Sa | Emulsions multiphasiques injectables |
JP2887485B2 (ja) * | 1989-08-09 | 1999-04-26 | 花王株式会社 | 油性化粧料 |
JPH04178316A (ja) * | 1990-11-09 | 1992-06-25 | Kao Corp | 乳化化粧料 |
US5262089A (en) * | 1990-12-12 | 1993-11-16 | Sandoz Ltd. | Admixtures for inhibiting corrosion of steel in concrete |
US5332595A (en) * | 1991-03-18 | 1994-07-26 | Kraft General Foods, Inc. | Stable multiple emulsions comprising interfacial gelatinous layer, flavor-encapsulating multiple emulsions and low/no-fat food products comprising the same |
FR2681246B1 (fr) * | 1991-04-05 | 1995-02-10 | Oreal | Composition cosmetique sous forme d'emulsion triple. |
DE4131678A1 (de) * | 1991-04-13 | 1992-10-15 | Beiersdorf Ag | Stabile multiple emulsionen |
DE69229779T2 (de) * | 1991-04-19 | 1999-12-23 | Lds Technologies, Inc. | Konvertierbare mikroemulsionsverbindungen |
US5688761A (en) * | 1991-04-19 | 1997-11-18 | Lds Technologies, Inc. | Convertible microemulsion formulations |
US5178871A (en) * | 1991-06-26 | 1993-01-12 | S. C. Johnson & Son, Inc. | Stable double emulsions containing finely-divided particles |
DE69225404T2 (de) * | 1991-06-27 | 1998-12-17 | Emory University, Atlanta, Ga. | Mehrkomponentemulsionen und verfahren zur deren herstellung |
US5622649A (en) * | 1991-06-27 | 1997-04-22 | Emory University | Multiple emulsions and methods of preparation |
FR2679788B1 (fr) * | 1991-08-02 | 1994-03-18 | Thorel Jean Noel | Structures d'emulsions polyphasiques autostabilisees. |
DE4136699A1 (de) * | 1991-11-07 | 1992-10-22 | Lancaster Group Ag | Verfahren zur herstellung von stabilen, komplexen emulsionssystemen des typs wasser-oel-wasser und deren verwendung als kosmetische praeparate |
US5213706A (en) * | 1991-11-08 | 1993-05-25 | Lever Brothers Company, Division Of Conopco, Inc. | Homogeneous detergent gel compositions for use in automatic dishwashers |
FR2693733B1 (fr) * | 1992-07-17 | 1994-09-16 | Oreal | Composition cosmétique sous forme d'émulsion triple eau/huile/eau gélifiée. |
US5322704A (en) * | 1992-09-25 | 1994-06-21 | Kraft General Foods, Inc. | Method for preparing a multiple emulsion |
FR2702373B1 (fr) * | 1993-03-08 | 1996-06-07 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
FR2702374B1 (fr) * | 1993-03-08 | 1995-04-14 | Rhone Merieux | Emulsions vaccinales fluides eau-dans-l'huile contenant une huile métabolisable. |
US5948825A (en) * | 1993-04-19 | 1999-09-07 | Institute For Advanced Skin Research Inc. | Microemulsion preparation containing a slightly absorbable substance |
DE4322174A1 (de) * | 1993-07-03 | 1995-01-12 | Goldschmidt Ag Th | Flüssige oder pastöse, lagerstabile, multiple Emulsion des Typs W·1·/O/W·2· |
US5372740A (en) * | 1993-09-03 | 1994-12-13 | Lever Brothers Company, Division Of Conopco, Inc. | Homogeneous liquid automatic dishwashing detergent composition based on sodium potassium tripolyphosphate |
US5498378A (en) * | 1993-11-12 | 1996-03-12 | Lever Brothers Company, Division Of Conopco, Inc. | Process for preparing capsules with structuring agents |
DE4341113B4 (de) * | 1993-12-02 | 2006-04-13 | IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG | Stabile multiple X/O/Y-Emulsion |
DE4343833A1 (de) * | 1993-12-22 | 1995-06-29 | Beiersdorf Ag | W/O/W-Emulsionen |
CA2180335A1 (en) * | 1993-12-30 | 1995-07-06 | Timothy J. Young | High internal phase water/oil emulsions and water/oil/water emulsions |
ES2169129T3 (es) * | 1994-04-18 | 2002-07-01 | Dsm Nv | Emulsiones estabilizadas de agua en aceite. |
US6013255A (en) * | 1994-04-18 | 2000-01-11 | Gist-Brocades B.V. | Stable water-in-oil emulsions |
US6136364A (en) * | 1994-09-08 | 2000-10-24 | Kraft Foods, Inc. | Microcapsule flavor delivery system |
US5656280A (en) * | 1994-12-06 | 1997-08-12 | Helene Curtis, Inc. | Water-in-oil-in-water compositions |
US5589177A (en) * | 1994-12-06 | 1996-12-31 | Helene Curtis, Inc. | Rinse-off water-in-oil-in-water compositions |
DE19505004C1 (de) * | 1995-02-15 | 1996-09-12 | Henkel Kgaa | Multiple W/O/W-Emulsionen und Verfahren zu deren Herstellung |
DE19509301A1 (de) * | 1995-03-15 | 1996-09-19 | Henkel Kgaa | Multiple W/O/W-Emulsionen |
US5626903A (en) * | 1995-06-07 | 1997-05-06 | Van Den Bergh Foods Co., Division Of Conopco, Inc. | Fat sparing system, especially for cookie filler cremes |
US5814321A (en) * | 1995-11-30 | 1998-09-29 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Oil adjuvant vaccine and method for preparing same |
US6071436A (en) * | 1995-12-01 | 2000-06-06 | Geo Specialty Chemicals, Inc. | Corrosion inhibitors for cement compositions |
DE19548016A1 (de) | 1995-12-21 | 1997-06-26 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen mit einem Gehalt an in gelöster Form vorliegenden, an sich schwerlöslichen UV-Filtersubstanzen, insbesondere Triazinderivaten |
DE19548014A1 (de) | 1995-12-21 | 1997-06-26 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an in fester, dispergierter Form vorliegenden, in Ölkomponenten schwerlöslichen oder unlöslichen UV-Filtersubstanzen |
DE19548013A1 (de) | 1995-12-21 | 1997-06-26 | Beiersdorf Ag | Verfahren zur Herstellung von O/W- oder O/W/O-Emulsionen sowie nach solchen Verfahren erhältliche O/W- und O/W/O-Emulsionen |
FR2752753B1 (fr) * | 1996-09-04 | 1999-12-17 | Henkel Kgaa | Procede de fabrication d'emulsions multiples w/o/w (eau-huile dans l'eau) |
DE19641604C1 (de) | 1996-10-09 | 1998-03-12 | Goldschmidt Ag Th | Polyglycerinpartialester von Fettsäuren und mehrfunktionellen Carbonsäuren, deren Herstellung und Verwendung |
DE19719297A1 (de) * | 1997-05-07 | 1998-11-12 | Henkel Kgaa | Verfahren zur Herstellung multipler W/O/W-Emulsionen |
GB9711786D0 (en) * | 1997-06-07 | 1997-08-06 | Ici Plc | Surfactant compositions |
DE19726189A1 (de) * | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen mit einem Gehalt an in gelöster Form vorliegenden s-Triazinderivaten |
DE19726184A1 (de) * | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an lichtschutzwirksamen Benzotriazolderivaten |
DE19726172A1 (de) * | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an s-Triazinderivaten |
DE19726121A1 (de) * | 1997-06-20 | 1998-12-24 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von Emulsionen, insbesondere O/W-Makroemulsionen, O/W-Mikroemulsionen oder O/W/O-Emulsionen, mit einem Gehalt an Bis-Resorcinyltriazinderivaten |
EP1020194A4 (en) | 1997-10-01 | 2003-05-21 | Wakamoto Pharma Co Ltd | OIL / WATER EMULSION COMPILATIONS |
EP1076547A4 (en) | 1998-04-27 | 2001-09-26 | Larex Inc | ARABINOGALACTANE DERIVATIVES AND COMPOSITIONS CONTAINING THEM |
FR2798601B1 (fr) * | 1999-09-20 | 2001-12-21 | Centre Nat Rech Scient | Emulsion double polydisperse, emulsion double monodisperse correspondante et procede de preparation de l'emulsion monodisperse |
DE19949826A1 (de) * | 1999-10-15 | 2001-04-19 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen in Form von O/W-Makroemulsionen oder O/W-Mikroemulsionen, mit einem Gehalt an Dihydroxyaceton |
US6406686B1 (en) * | 2000-03-21 | 2002-06-18 | Amway Corporation | Conditioning shampoo containing arabinogalactan |
WO2002043697A1 (fr) * | 2000-11-29 | 2002-06-06 | Taisho Pharmaceutical Co.,Ltd. | Emulsion composite e/h/e |
EP1346721A4 (en) * | 2000-11-29 | 2009-04-29 | Taisho Pharmaceutical Co Ltd | COMPOSITE EMULSION W / O |
KR100435921B1 (ko) * | 2000-12-29 | 2004-06-12 | 주식회사 태평양 | 동수역학적 이중 안정화에 의한 안정한 수-유-수 다중에멀젼 시스템 및 이의 제조방법 |
FR2823450B1 (fr) * | 2001-04-12 | 2004-08-27 | Rhodia Chimie Sa | Suspension obtenue a partir d'une emulsion multiple comprenant un compose hydrophobe solide a temperature ambiante et granules obtenus par sechage de la suspension |
DE10120927A1 (de) * | 2001-04-30 | 2002-10-31 | Stockhausen Chem Fab Gmbh | Verwendung von multiplen Emulsionen als Hautschutzprodukte |
FR2833184B1 (fr) * | 2001-12-11 | 2004-01-23 | Rhodia Chimie Sa | Procede de preparation d'une emulsion multiple de type eau/huile/eau |
JP4822092B2 (ja) * | 2003-09-01 | 2011-11-24 | 大正製薬株式会社 | W/o/w型複合エマルション |
US20090156385A1 (en) * | 2003-10-29 | 2009-06-18 | Giang Biscan | Manufacture and use of engineered carbide and nitride composites |
DE10351644A1 (de) * | 2003-11-05 | 2005-06-09 | Bayer Technology Services Gmbh | Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen |
JP2005145937A (ja) * | 2003-11-19 | 2005-06-09 | Sekisui Chem Co Ltd | 多孔質セラミックフィルタ成形用造孔剤及び吸油性もしくは吸水性化粧用粒子 |
FR2868305B1 (fr) | 2004-04-02 | 2006-06-30 | Oreal | Procede de traitement capillaire et utilisation dudit procede |
US20060083702A1 (en) * | 2004-04-02 | 2006-04-20 | Thomas Fondin | Hair fiber treating method |
US7976831B2 (en) * | 2004-04-02 | 2011-07-12 | L'oreal S.A. | Method for treating hair fibers |
DE102006004353A1 (de) * | 2006-01-30 | 2007-08-02 | Goldschmidt Gmbh | Kaltherstellbare, niedrigviskose und langzeitstabile kosmetische Emulsionen |
JP5026764B2 (ja) * | 2006-10-18 | 2012-09-19 | 花王株式会社 | W/o/w型エマルジョンを含有する洗浄剤組成物 |
KR101538295B1 (ko) | 2006-12-28 | 2015-07-22 | 다우 코닝 코포레이션 | 다핵성 미세캡슐 |
US20100102142A1 (en) * | 2008-10-28 | 2010-04-29 | Daria Tagliareni | Scent dispenser assembly |
WO2010074257A1 (ja) * | 2008-12-26 | 2010-07-01 | 株式会社J-オイルミルズ | 油脂組成物 |
JP4731610B2 (ja) * | 2009-03-06 | 2011-07-27 | ライオン株式会社 | W/o/w型複合エマルション |
US10688026B2 (en) | 2009-04-27 | 2020-06-23 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
US9814657B2 (en) | 2009-04-27 | 2017-11-14 | Premier Dental Products Company | Buffered microencapsulated compositions and methods |
US8241615B2 (en) * | 2009-10-19 | 2012-08-14 | L'oreal S.A. | Water-resistant sunscreen composition |
EP2502617B1 (en) * | 2009-11-20 | 2019-03-20 | Konica Minolta Holdings, Inc. | Process for production of w/o/w emulsion, process for production of liposome employing the process, and porous membrane for use in the methods |
US20110274627A1 (en) * | 2010-05-06 | 2011-11-10 | Ali Abdelaziz Alwattari | Method Of Making An Aerosol Shave Composition Comprising A Hydrophobical Agent Forming At Least One Microdroplet |
JP5647862B2 (ja) * | 2010-10-29 | 2015-01-07 | 阪本薬品工業株式会社 | 燃料用w/o乳化剤 |
JP2012095561A (ja) * | 2010-10-29 | 2012-05-24 | Sakamoto Yakuhin Kogyo Co Ltd | ポリグリセリン縮合リシノール酸エステルを含む食品 |
US20130065970A1 (en) * | 2011-07-08 | 2013-03-14 | Jakob BREDSGUARD | Compositions and products containing estolide compounds |
KR20180003600A (ko) * | 2015-05-06 | 2018-01-09 | 애그로프레쉬 인크. | 캡슐화된 휘발성 화합물의 안정적인 에멀전 제제 |
FR3049855A1 (fr) * | 2016-04-12 | 2017-10-13 | Oleon Nv | Emulsion multiple |
FR3053587B1 (fr) * | 2016-07-06 | 2019-07-05 | Oleon Nv | Composition notamment de type emulsion multiple et procede de preparation |
FR3070861B1 (fr) * | 2017-09-11 | 2020-03-27 | Oleon Nv | Combinaison emulsifiante pour l'obtention d'emulsions eau-dans-huile de faible viscosite |
KR102056307B1 (ko) | 2018-01-26 | 2019-12-16 | 한국과학기술원 | 상전이법에 의해 제조된 이중 에멀전 및 이의 제조방법 |
EP3662756A1 (en) * | 2018-12-07 | 2020-06-10 | General Mills, Inc. | Multiple emulsions, method of making them and applications in food, cosmetics and pharmaceuticals |
TWI758750B (zh) * | 2020-06-17 | 2022-03-21 | 財團法人食品工業發展研究所 | 製備水包油包水型多重乳液之方法 |
JP7082846B1 (ja) * | 2021-04-28 | 2022-06-09 | Caetus Technology株式会社 | 頭皮保護用組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5590141A (en) * | 1978-12-27 | 1980-07-08 | Marantz Japan Inc | Frequency control system |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2785978A (en) * | 1951-04-10 | 1957-03-19 | Lever Brothers Ltd | Surface active compounds and method for the production thereof |
US3399263A (en) * | 1965-04-12 | 1968-08-27 | American Cyanamid Co | Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid |
GB1235667A (en) * | 1967-07-19 | 1971-06-16 | Nat Res Dev | Improvements in or relating to sustained release preparations |
LU67772A1 (ja) * | 1973-06-08 | 1975-03-06 | ||
US4328149A (en) * | 1980-01-30 | 1982-05-04 | Calgon Corporation | Polymerization method utilizing a three-phase emulsion system |
JPS602903B2 (ja) * | 1980-07-02 | 1985-01-24 | 株式会社資生堂 | 多相型エマルションの調製方法 |
JPS58175475A (ja) * | 1982-04-08 | 1983-10-14 | Q P Corp | 水中油中水型乳化食品 |
US4454113A (en) * | 1982-09-21 | 1984-06-12 | Scm Corporation | Stabilization of oil and water emulsions using polyglycerol esters of fatty acids |
JPS5962340A (ja) * | 1982-10-01 | 1984-04-09 | Meiji Milk Prod Co Ltd | W101w型複合エマルジョンの製造法 |
DE3390056T (de) * | 1982-10-01 | 1984-11-15 | Meiji Milk Products Co. Ltd., Tokyo | Verfahren zur Herstellung einer W/O/W-Öl- und -Fettzusammensetzung für Nahrungsmittel |
JPS59169531A (ja) * | 1983-03-18 | 1984-09-25 | Meiji Milk Prod Co Ltd | W/o/w型複合エマルジヨンの製造法 |
NL8401026A (nl) * | 1983-11-09 | 1985-06-03 | Unilever Nv | Eetbare w/o/w emulsie. |
NL8303848A (nl) * | 1983-11-09 | 1985-06-03 | Unilever Nv | Eetbare w/o/w emulsie. |
US4626443A (en) * | 1984-03-02 | 1986-12-02 | Meiji Milk Products Company Limited | Process for preparing dressings comprising W/O/W type multiple emulsions |
US4626444A (en) * | 1984-03-02 | 1986-12-02 | Meiji Milk Products Company Limited | Process for preparation of dressings comprising W/O/W type multiple emulsions |
JPS60184366A (ja) * | 1984-03-02 | 1985-09-19 | Meiji Milk Prod Co Ltd | W/o/w型複合乳化ドレツシング類 |
JPS60199833A (ja) * | 1984-03-26 | 1985-10-09 | Meiji Milk Prod Co Ltd | 医薬品、化粧品等用w/o/w型複合エマルジヨンの製造法 |
JPH08215829A (ja) * | 1995-02-16 | 1996-08-27 | Unisia Jecs Corp | 鋳ぐるみ方法 |
-
1984
- 1984-03-26 JP JP59056324A patent/JPS60199833A/ja not_active Expired - Lifetime
-
1985
- 1985-03-25 EP EP85901572A patent/EP0174377B2/en not_active Expired
- 1985-03-25 WO PCT/JP1985/000143 patent/WO1985004346A1/ja active IP Right Grant
- 1985-03-25 NL NL8520061A patent/NL8520061A/nl not_active Application Discontinuation
- 1985-03-25 DE DE19853590135 patent/DE3590135T1/de not_active Ceased
- 1985-03-25 GB GB08524315A patent/GB2165163B/en not_active Expired
-
1988
- 1988-09-19 US US07/247,116 patent/US4931210A/en not_active Expired - Lifetime
- 1988-09-19 US US07/247,115 patent/US4971721A/en not_active Expired - Lifetime
-
1989
- 1989-07-10 US US07/376,943 patent/US4988456A/en not_active Expired - Lifetime
-
1990
- 1990-05-29 US US07/530,053 patent/US4985173A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5590141A (en) * | 1978-12-27 | 1980-07-08 | Marantz Japan Inc | Frequency control system |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, Vol. 87, No. 7, 15 August 1977 (15. 08. 77) 51763e * |
See also references of EP0174377A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4409569C1 (de) * | 1994-03-21 | 1995-08-10 | Henkel Kgaa | Polyglycerinpolyricinoleate |
US5840943A (en) * | 1994-06-13 | 1998-11-24 | Henkel Kommanditgesellschaft Auf Aktien | Polyolpolyhydroxystearates |
US6264961B1 (en) | 1995-09-11 | 2001-07-24 | Henkel Kommanditgesellschaft Auf Aktien | Oil-water emulsifiers |
WO2014045410A1 (ja) * | 2012-09-21 | 2014-03-27 | キユーピー株式会社 | 乳化調味料 |
Also Published As
Publication number | Publication date |
---|---|
GB8524315D0 (en) | 1985-11-06 |
EP0174377B1 (en) | 1988-11-17 |
US4931210A (en) | 1990-06-05 |
DE3590135T1 (de) | 1986-05-15 |
US4971721A (en) | 1990-11-20 |
EP0174377A1 (en) | 1986-03-19 |
JPS60199833A (ja) | 1985-10-09 |
EP0174377B2 (en) | 1992-05-13 |
EP0174377A4 (en) | 1987-09-10 |
GB2165163A (en) | 1986-04-09 |
GB2165163B (en) | 1988-05-25 |
NL8520061A (nl) | 1986-01-02 |
US4985173A (en) | 1991-01-15 |
US4988456A (en) | 1991-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1985004346A1 (en) | Process for preparing w/o/w complex emulsion for medicinal and cosmetic use | |
JP4243587B2 (ja) | 食品に適用するための香味付けされた水中油型エマルジョン | |
KR100991675B1 (ko) | 식물 정유를 함유하는 나노에멀션과 나노입자 및 그제조방법 | |
KR101116899B1 (ko) | 안정한 농축형 및 희석형 수중유형 에멀젼 | |
JPH0231834A (ja) | エマルジョン製品およびその製造法 | |
JPS62419A (ja) | 脂溶性ビタミン含有水溶性剤 | |
JPS60183031A (ja) | W/o/w型複合エマルジヨンの製造法 | |
JP6739493B2 (ja) | キャンデリラロウ分散組成物 | |
WO2002043698A1 (fr) | Emulsion composite e/h/e | |
JPH0356777B2 (ja) | ||
JP3358225B2 (ja) | 水溶性化合物油溶化製剤およびその製造方法 | |
JP2012223161A (ja) | 植物由来成分及び乳脂肪球皮膜を含む組成物 | |
JPH04149194A (ja) | レシチン―ステロール複合体及びその製造方法 | |
JPS62289160A (ja) | 乳化香料の製造方法 | |
US8709456B2 (en) | Liquid-filled protein-phosphatidic acid capsule dispersions | |
JP6242422B2 (ja) | 化粧品原料の製造方法 | |
JPS60193529A (ja) | W/o/w型エマルジヨンの製造方法 | |
JPS60203139A (ja) | 食品用w/o/w型複合エマルジヨンの製造法 | |
JP4437885B2 (ja) | 二重乳化油脂組成物およびその製造法 | |
JP2003095925A (ja) | 複合エマルションの製造方法 | |
JPH0435212B2 (ja) | ||
JPS6239008B2 (ja) | ||
JPS62221629A (ja) | リン脂質乳剤の製造方法 | |
WO2002043697A1 (fr) | Emulsion composite e/h/e | |
JPH0424974B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): DE GB NL US |
|
AL | Designated countries for regional patents |
Designated state(s): FR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1985901572 Country of ref document: EP |
|
EL | Fr: translation of claims filed | ||
WWP | Wipo information: published in national office |
Ref document number: 1985901572 Country of ref document: EP |
|
WR | Later publication of a revised version of an international search report | ||
RET | De translation (de og part 6b) |
Ref document number: 3590135 Country of ref document: DE Date of ref document: 19860515 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3590135 Country of ref document: DE |
|
WWG | Wipo information: grant in national office |
Ref document number: 1985901572 Country of ref document: EP |